Hylobates moloch (silvery gibbon): 116466067
Help
Entry
116466067 CDS
T08803
Symbol
CASP3
Name
(RefSeq) caspase-3 isoform X1
KO
K02187
caspase 3 [EC:
3.4.22.56
]
Organism
hmh
Hylobates moloch (silvery gibbon)
Pathway
hmh01524
Platinum drug resistance
hmh04010
MAPK signaling pathway
hmh04115
p53 signaling pathway
hmh04148
Efferocytosis
hmh04210
Apoptosis
hmh04215
Apoptosis - multiple species
hmh04623
Cytosolic DNA-sensing pathway
hmh04650
Natural killer cell mediated cytotoxicity
hmh04657
IL-17 signaling pathway
hmh04668
TNF signaling pathway
hmh04726
Serotonergic synapse
hmh04932
Non-alcoholic fatty liver disease
hmh04933
AGE-RAGE signaling pathway in diabetic complications
hmh04936
Alcoholic liver disease
hmh05010
Alzheimer disease
hmh05012
Parkinson disease
hmh05014
Amyotrophic lateral sclerosis
hmh05016
Huntington disease
hmh05020
Prion disease
hmh05022
Pathways of neurodegeneration - multiple diseases
hmh05132
Salmonella infection
hmh05133
Pertussis
hmh05134
Legionellosis
hmh05145
Toxoplasmosis
hmh05146
Amoebiasis
hmh05152
Tuberculosis
hmh05160
Hepatitis C
hmh05161
Hepatitis B
hmh05162
Measles
hmh05163
Human cytomegalovirus infection
hmh05164
Influenza A
hmh05165
Human papillomavirus infection
hmh05167
Kaposi sarcoma-associated herpesvirus infection
hmh05168
Herpes simplex virus 1 infection
hmh05169
Epstein-Barr virus infection
hmh05170
Human immunodeficiency virus 1 infection
hmh05200
Pathways in cancer
hmh05203
Viral carcinogenesis
hmh05205
Proteoglycans in cancer
hmh05206
MicroRNAs in cancer
hmh05210
Colorectal cancer
hmh05222
Small cell lung cancer
hmh05416
Viral myocarditis
hmh05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
hmh00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
116466067 (CASP3)
04668 TNF signaling pathway
116466067 (CASP3)
09140 Cellular Processes
09141 Transport and catabolism
04148 Efferocytosis
116466067 (CASP3)
09143 Cell growth and death
04210 Apoptosis
116466067 (CASP3)
04215 Apoptosis - multiple species
116466067 (CASP3)
04115 p53 signaling pathway
116466067 (CASP3)
09150 Organismal Systems
09151 Immune system
04623 Cytosolic DNA-sensing pathway
116466067 (CASP3)
04650 Natural killer cell mediated cytotoxicity
116466067 (CASP3)
04657 IL-17 signaling pathway
116466067 (CASP3)
09156 Nervous system
04726 Serotonergic synapse
116466067 (CASP3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
116466067 (CASP3)
05206 MicroRNAs in cancer
116466067 (CASP3)
05205 Proteoglycans in cancer
116466067 (CASP3)
05203 Viral carcinogenesis
116466067 (CASP3)
09162 Cancer: specific types
05210 Colorectal cancer
116466067 (CASP3)
05222 Small cell lung cancer
116466067 (CASP3)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
116466067 (CASP3)
05161 Hepatitis B
116466067 (CASP3)
05160 Hepatitis C
116466067 (CASP3)
05164 Influenza A
116466067 (CASP3)
05162 Measles
116466067 (CASP3)
05168 Herpes simplex virus 1 infection
116466067 (CASP3)
05163 Human cytomegalovirus infection
116466067 (CASP3)
05167 Kaposi sarcoma-associated herpesvirus infection
116466067 (CASP3)
05169 Epstein-Barr virus infection
116466067 (CASP3)
05165 Human papillomavirus infection
116466067 (CASP3)
09171 Infectious disease: bacterial
05132 Salmonella infection
116466067 (CASP3)
05133 Pertussis
116466067 (CASP3)
05134 Legionellosis
116466067 (CASP3)
05152 Tuberculosis
116466067 (CASP3)
09174 Infectious disease: parasitic
05146 Amoebiasis
116466067 (CASP3)
05145 Toxoplasmosis
116466067 (CASP3)
09164 Neurodegenerative disease
05010 Alzheimer disease
116466067 (CASP3)
05012 Parkinson disease
116466067 (CASP3)
05014 Amyotrophic lateral sclerosis
116466067 (CASP3)
05016 Huntington disease
116466067 (CASP3)
05020 Prion disease
116466067 (CASP3)
05022 Pathways of neurodegeneration - multiple diseases
116466067 (CASP3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
116466067 (CASP3)
05416 Viral myocarditis
116466067 (CASP3)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
116466067 (CASP3)
04932 Non-alcoholic fatty liver disease
116466067 (CASP3)
04933 AGE-RAGE signaling pathway in diabetic complications
116466067 (CASP3)
09176 Drug resistance: antineoplastic
01524 Platinum drug resistance
116466067 (CASP3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01002 Peptidases and inhibitors [BR:
hmh01002
]
116466067 (CASP3)
Enzymes [BR:
hmh01000
]
3. Hydrolases
3.4 Acting on peptide bonds (peptidases)
3.4.22 Cysteine endopeptidases
3.4.22.56 caspase-3
116466067 (CASP3)
Peptidases and inhibitors [BR:
hmh01002
]
Cysteine peptidases
Family C14: caspase family
116466067 (CASP3)
BRITE hierarchy
SSDB
Ortholog
Paralog
GFIT
Motif
Pfam:
Peptidase_C14
Motif
Other DBs
NCBI-GeneID:
116466067
NCBI-ProteinID:
XP_032004893
EnsemblRapid:
ENSHMOG00005025107
LinkDB
All DBs
Position
Unknown
AA seq
277 aa
AA seq
DB search
MENTENSVDSKSIKNLEPKIIHGSKSMDSGISLDNSYKMDYPEMGLCIIINNKNFHKSTG
MASRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLS
HGEEGIIFGTNGPVDLRKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDD
DMACHKIPVEADFLYAYSTAPGYYSWRNSRDGSWFIQSLCAMLKQYADKLEFMHILTRVN
RKVATEFESFSLDATFHAKKQIPCIVSMLTKELYFYH
NT seq
834 nt
NT seq
+upstream
nt +downstream
nt
atggagaacactgaaaactcagtggattcaaaatccattaaaaatttggaaccaaagatc
atacatggaagcaaatcaatggactctggaatatccctggacaacagttataaaatggat
tatcctgagatgggtttatgtataataattaataataagaattttcataaaagcactgga
atggcatctcggtctggtacagatgtcgatgcagcaaacctcagggaaacattcagaaac
ttgaagtatgaagtcaggaataaaaatgatcttacacgtgaagaaattgtggaattgatg
cgtgatgtttctaaagaagatcacagcaaaaggagcagttttgtttgtgtgcttctgagc
catggtgaagaaggaataatttttggaacaaatggacctgttgacttgagaaaaataaca
aactttttcagaggggatcgttgtagaagtctaactggaaaacccaaacttttcattatt
caggcctgccgtggtacagaactggactgtggcattgagacagacagtggtgttgatgat
gacatggcgtgtcataaaataccagtggaggcggacttcttgtatgcatactccacagca
cctggttattattcttggcgaaattcaagggatggctcctggttcatccagtcgctttgt
gccatgctgaaacagtacgccgacaagcttgaatttatgcacattcttacccgggttaac
cgaaaggtggcaacagaatttgagtccttttcccttgatgctacttttcatgcaaagaaa
cagattccatgtattgtttccatgctcacaaaagaactctatttttatcactaa
DBGET
integrated database retrieval system